Mohammad Azab Caladrius Biosciences, Inc. (CLBS) insider trading activity

CLBS Quotes by TradingView

Mohammad Azab is Director of CALADRIUS BIOSCIENCES, INC.. Currently has a direct ownership of 74,469 shares of CLBS, which is worth approximately $262,130. The most recent transaction as insider was on Jan 09, 2025, when has been sold 15,789 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 74.5K
26.91% 3M change
26.91% 12M change
Total Value Held $262,130

MOHAMMAD AZAB Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 09 2025
BUY
Grant, award, or other acquisition
-
15,789 Added 17.49%
74,469 Common Stock
Jan 09 2024
BUY
Grant, award, or other acquisition
-
19,480 Added 24.92%
58,680 Common Stock
Jan 09 2023
BUY
Grant, award, or other acquisition
-
20,000 Added 33.78%
39,200 Common Stock
Sep 15 2022
BUY
Grant, award, or other acquisition
$120,000 $6.25 p/Share
19,200 Added 50.0%
19,200 Common Stock

Also insider at

XENE
Xenon Pharmaceuticals Inc. Healthcare
DRRX
DURECT CORP Healthcare
MA

Mohammad Azab

Director
Basking Ridge, NJ

Track Institutional and Insider Activities on CLBS

Follow CALADRIUS BIOSCIENCES, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CLBS shares.

Notify only if

Insider Trading

Get notified when an Caladrius Biosciences, Inc. insider buys or sells CLBS shares.

Notify only if

News

Receive news related to CALADRIUS BIOSCIENCES, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CLBS